| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70462 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77065-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77275-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73912 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-73970 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-65729SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB200-610-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-63255-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-59072-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-62994-0.2mg | |||
| BSA Free | NB100-62994-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-77278-0.025mg | |||
![Western Blot: GM-CSF Antibody (8G5) [NBP2-46364] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY GM-CSF.](http://images.novusbio.com/fullsize/GM-CSF-Antibody-8G5-Western-Blot-NBP2-46364-img0006.jpg "Western Blot: GM-CSF Antibody (8G5) [NBP2-46364] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY GM-CSF.")
![Immunohistochemistry: GM-CSF Antibody (8G5) [NBP2-46364] - Analysis of Human tonsil tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/GM-CSF-Antibody-8G5-Immunohistochemistry-NBP2-46364-img0005.jpg)
![Immunohistochemistry: GM-CSF Antibody (8G5) [NBP2-46364] - Analysis of Carcinoma of Human liver tissue.(Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/GM-CSF-Antibody-8G5-Immunohistochemistry-NBP2-46364-img0001.jpg)
![Immunohistochemistry: GM-CSF Antibody (8G5) [NBP2-46364] - Analysis of Human pancreas tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/GM-CSF-Antibody-8G5-Immunohistochemistry-NBP2-46364-img0002.jpg)
![Immunohistochemistry: GM-CSF Antibody (8G5) [NBP2-46364] - Analysis of Human lymph node tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/GM-CSF-Antibody-8G5-Immunohistochemistry-NBP2-46364-img0003.jpg)
![Immunohistochemistry: GM-CSF Antibody (8G5) [NBP2-46364] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by 1mM EDTA in 10mM Tris buffer (pH8.5) at 120C for 3 min)](http://images.novusbio.com/fullsize/GM-CSF-Antibody-8G5-Immunohistochemistry-NBP2-46364-img0004.jpg)
![Western Blot: CCR3 Antibody [NBP1-77065] - Human spleen tissue lysates with CCR3 antibody at 1 (lane 1) and 2 ug/ml (lane 2), and 2 ug/ml in the presence of blocking peptide (lane 3).](http://images.novusbio.com/fullsize/CCR3-Antibody-Western-Blot-NBP1-77065-img0002.jpg "Western Blot: CCR3 Antibody [NBP1-77065] - Human spleen tissue lysates with CCR3 antibody at 1 (lane 1) and 2 ug/ml (lane 2), and 2 ug/ml in the presence of blocking peptide (lane 3).")
![Immunohistochemistry-Paraffin: CCR3 Antibody [NBP1-77065] - Human spleen tissue with CCR3 antibody at 10 ug/ml.](http://images.novusbio.com/fullsize/CCR3-Antibody-Immunohistochemistry-Paraffin-NBP1-77065-img0001.jpg)
![Immunocytochemistry/ Immunofluorescence: CCR3 Antibody - BSA Free [NBP1-77065] - Immunofluorescence of CCR3 in Human Spleen tissue with CCR3 antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77065_rabbit-polyclonal-ccr3-antibody-2711202420285882.jpg)
![Western Blot: MAVS Antibody [NBP1-77275] - A20 cell lysate with MAVS antibody at (A) 0.5, (B) 1 and (C) 2 ug/ml.](http://images.novusbio.com/fullsize/MAVS-Antibody-Western-Blot-NBP1-77275-img0001.jpg "Western Blot: MAVS Antibody [NBP1-77275] - A20 cell lysate with MAVS antibody at (A) 0.5, (B) 1 and (C) 2 ug/ml.")
![Immunohistochemistry-Paraffin: MAVS Antibody [NBP1-77275] - Human brain tissue with MAVS antibody at 5 ug/ml.](http://images.novusbio.com/fullsize/MAVS-Antibody-Immunohistochemistry-Paraffin-NBP1-77275-img0003.jpg)
![Immunocytochemistry/ Immunofluorescence: MAVS Antibody - BSA Free [NBP1-77275] - Immunofluorescence of MAVS in Human Brain cells with MAVS antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77275_rabbit-polyclonal-mavs-antibody-2711202420432381.jpg)
![Western Blot: RIPK3/RIP3 Antibody (OTI1B3) [NBP2-45592] - Analysis of RIPK3/RIP3 using RIPK3/RIP3 antibody (OTI1B3) [NBP2-45592] in HEK293T cells transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RIPK3. Observed molecular weight ~55 kDa. Theoretical molecular weight 56.7 kDa.](http://images.novusbio.com/fullsize/RIPK3-RIP3-Antibody-1B3-Western-Blot-NBP2-45592-img0004.jpg "<b>Genetic Strategies Validation. </b>Western Blot: RIPK3/RIP3 Antibody (OTI1B3) [NBP2-45592] - Analysis of RIPK3/RIP3 using RIPK3/RIP3 antibody (OTI1B3) [NBP2-45592] in HEK293T cells transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY RIPK3. Observed molecular weight ~55 kDa. Theoretical molecular weight 56.7 kDa.")
![<b>Genetic Strategies Validation. </b>Immunohistochemistry: RIPK3/RIP3 Antibody (OTI1B3) [NBP2-45592] - Analysis of Human Kidney tissue using RIPK3/RIP3 Antibody [NBP2-45592]. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH9.0, 120C for 3min)](http://images.novusbio.com/fullsize/RIPK3-RIP3-Antibody-1B3-Immunohistochemistry-NBP2-45592-img0001.jpg)
![Immunohistochemistry: RIPK3/RIP3 Antibody (OTI1B3) [NBP2-45592] - Analysis of Carcinoma of Human thyroid tissue using RIPK3/RIP3 Antibody [NBP2-45592]. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH9.0, 120C for 3min)](http://images.novusbio.com/fullsize/RIPK3-RIP3-Antibody-1B3-Immunohistochemistry-NBP2-45592-img0003.jpg)
![Western Blot: RIPK3/RIP3 Antibody (OTI1B3) [NBP2-45592] - Analysis of extracts (10ug) from 2 different cell lines using RIPK3/RIP3 antibody (OTI1B3) [NBP2-45592]. Observed molecular weight ~55 kDa. Theoretical molecular weight 56.7 kDa.](http://images.novusbio.com/fullsize/RIPK3-RIP3-Antibody-1B3-Western-Blot-NBP2-45592-img0005.jpg)
![Immunohistochemistry: RIPK3/RIP3 Antibody (OTI1B3) [NBP2-45592] - Analysis of Carcinoma of Human pancreas tissue using RIPK3/RIP3 Antibody [NBP2-45592]. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH9.0, 120C for 3min)](http://images.novusbio.com/fullsize/RIPK3-RIP3-Antibody-1B3-Immunohistochemistry-NBP2-45592-img0002.jpg)
![Western Blot: S100A9 Antibody (10D5) [NBP2-45662] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY S100A9 .](http://images.novusbio.com/fullsize/S100A9-Antibody-10D5-Western-Blot-NBP2-45662-img0007.jpg "Western Blot: S100A9 Antibody (10D5) [NBP2-45662] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY S100A9 .")
![Immunohistochemistry: S100A9 Antibody (10D5) [NBP2-45662] - Analysis of Human tonsil tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/S100A9-Antibody-10D5-Immunohistochemistry-NBP2-45662-img0006.jpg)
![Immunohistochemistry: S100A9 Antibody (10D5) [NBP2-45662] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/S100A9-Antibody-10D5-Immunohistochemistry-NBP2-45662-img0001.jpg)
![Immunohistochemistry: S100A9 Antibody (10D5) [NBP2-45662] - Analysis of Carcinoma of Human lung tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/S100A9-Antibody-10D5-Immunohistochemistry-NBP2-45662-img0002.jpg)
![Immunohistochemistry: S100A9 Antibody (10D5) [NBP2-45662] - Analysis of Carcinoma of Human prostate tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/S100A9-Antibody-10D5-Immunohistochemistry-NBP2-45662-img0003.jpg)
![Immunohistochemistry: S100A9 Antibody (10D5) [NBP2-45662] - Analysis of Human lymph node tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/S100A9-Antibody-10D5-Immunohistochemistry-NBP2-45662-img0004.jpg)
![Immunohistochemistry: S100A9 Antibody (10D5) [NBP2-45662] - Analysis of Human lymphoma tissue. (Heat-induced epitope retrieval by 1 mM EDTA in 10mM Tris, pH8.5, 120C for 3min)](http://images.novusbio.com/fullsize/S100A9-Antibody-10D5-Immunohistochemistry-NBP2-45662-img0005.jpg)
![Dual RNAscope ISH-IHC: CD8 Antibody (4B11) [NB100-65729] - Formalin-fixed paraffin-embedded tissue sections of human tonsil were probed for CD8 mRNA (ACD RNAScope probe, catalog # 560391; Fast Red chromogen, ACD catalog # 322500) followed by immunohistochemistry using mouse monoclonal (Novus catalog # NB100-65729) at 5ug/mL for 1 hour at room temperature and detection with anti-mouse IgG VisUCyte HRP Polymer Antibody (R&D Systems Catalog # VC001) and green HRP chromogen (ACD Catalog # 322500).](http://images.novusbio.com/fullsize/CD8-Antibody-4B11-Dual-RNAscope-ISH-IHC-NB100-65729-img0003.jpg "<b>Orthogonal Strategies Validation. </b>Dual RNAscope ISH-IHC: CD8 Antibody (4B11) [NB100-65729] - Formalin-fixed paraffin-embedded tissue sections of human tonsil were probed for CD8 mRNA (ACD RNAScope probe, catalog # 560391; Fast Red chromogen, ACD catalog # 322500) followed by immunohistochemistry using mouse monoclonal (Novus catalog # NB100-65729) at 5ug/mL for 1 hour at room temperature and detection with anti-mouse IgG VisUCyte HRP Polymer Antibody (R&D Systems Catalog # VC001) and green HRP chromogen (ACD Catalog # 322500).")
![<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CD8 Antibody (4B11) [NB100-65729] - Analysis of formalin fixed, paraffin-embedded human tonsil with CD8 Antibody (4B11). Magnification: 40X.](http://images.novusbio.com/fullsize/CD8-alpha-Antibody-4B11-Immunohistochemistry-Paraffin-NB100-65729-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: Integrin beta 2/CD18 Antibody (YFC118.3) [NB200-610] - A-D Confocal microscopy of IBA-1 (green staining) immunohistochemistry of RPE flatmounts (RPE autofluorescence visible as orange due to its autofluorescence in the red and green channel) from a healthy donor (A), a geographic atrophy lesion (B), and large drusen (C and D). (A, B, D): orthogonal Z-stack projection; (C): oblique Z-stack projection and dissecting microscope appearance of postmortem large drusen after removal of the overlaying retina (inset). E-G Double-labeling on the subretinal side of the retina (to avoid masking by RPE autofluorescence) of IBA-1+ (E, green fluorescence) and CD18 (F, red fluorescence; G, merge). H. Orthogonal and lateral Z-stack of a subretinal IBA-1+ (green fluorescence) MPs adjacent to the RPE (orange autofluorescence) in the vicinity of a large drusen.](http://images.novusbio.com/fullsize/Integrin-beta-2-CD18-Antibody-YFC118-3-Immunocytochemistry-Immunofluorescence-NB200-610-img0011.jpg "Immunocytochemistry/Immunofluorescence: Integrin beta 2/CD18 Antibody (YFC118.3) [NB200-610] - A-D Confocal microscopy of IBA-1 (green staining) immunohistochemistry of RPE flatmounts (RPE autofluorescence visible as orange due to its autofluorescence in the red and green channel) from a healthy donor (A), a geographic atrophy lesion (B), and large drusen (C and D). (A, B, D): orthogonal Z-stack projection; (C): oblique Z-stack projection and dissecting microscope appearance of postmortem large drusen after removal of the overlaying retina (inset). E-G Double-labeling on the subretinal side of the retina (to avoid masking by RPE autofluorescence) of IBA-1+ (E, green fluorescence) and CD18 (F, red fluorescence; G, merge). H. Orthogonal and lateral Z-stack of a subretinal IBA-1+ (green fluorescence) MPs adjacent to the RPE (orange autofluorescence) in the vicinity of a large drusen.")
![Immunohistochemistry-Frozen: Integrin beta 2/CD18 Antibody (YFC118.3) [NB200-610] - Canine histiocytic sarcoma stained with Integrin beta 2/CD18 Antibody (YFC118.3). IHC-Fr image submitted by a verified customer review.](http://images.novusbio.com/fullsize/Integrin-beta-2-CD18-Antibody-YFC118-3-Immunohistochemistry-Frozen-NB200-610-img0018.jpg)
![Flow Cytometry: Integrin beta 2/CD18 Antibody (YFC118.3) [NB200-610] - Staining of human peripheral blood granulocytes with RAT ANTI HUMAN CD18: FITC.](http://images.novusbio.com/fullsize/Integrin-beta-2-CD18-Antibody-YFC118-3-Flow-Cytometry-NB200-610-img0017.jpg)
![Immunocytochemistry/Immunofluorescence: Integrin beta 2/CD18 Antibody (YFC118.3) [NB200-610] - Analysis of canine thoracic fluid samples using anti-Integrin beta 2 antibody. The antibody showing positive cell surface staining. ICC/IF image submitted by a verified customer review.](http://images.novusbio.com/fullsize/Integrin-beta-2-CD18-Antibody-YFC118-3-Immunocytochemistry-Immunofluorescence-NB200-610-img0007.jpg)
![Flow Cytometry: Integrin beta 2/CD18 Antibody (YFC118.3) [NB200-610] - Staining of human peripheral blood lymphocytes with Rat anti Human CD18.](http://images.novusbio.com/fullsize/Integrin-beta-2-CD18-Antibody-YFC118-3-Flow-Cytometry-NB200-610-img0001.jpg)
![Flow Cytometry: Integrin beta 2/CD18 Antibody (YFC118.3) [NB200-610] - A) Isotype control with macrophages showing delineation of the M1 marker based on the negative population. B and C represent expression of CD18 (B) or CD11b (C) before incubation with Leishmania. D and E represent expression of CD18 (D) or CD11b (E) after association with Leishmania in a SD assay. In all cases the percent positive cells within the M1 marker are identified. This Figure is a representative diagram of 4 experiments with similar findings.](http://images.novusbio.com/fullsize/Integrin-beta-2-CD18-Antibody-YFC118-3-Flow-Cytometry-NB200-610-img0008.jpg)
![Flow Cytometry: Integrin beta 2/CD18 Antibody (YFC118.3) [NB200-610] - LFA-1 activation analyses by Flow Cytometry. (A) Profiles of CD11a, CD18 activation epitope (CD18act, representing high affinity conformation) and CD18 (CD18tot) expression by Teff and Treg#1 cells pre-incubated or not with indicated antibodies. Anti-CD28 and anti-CTLA-4 were used at 10 ug/ml. (B) Histograms of Mean Fluorescent Intensity (MFI) of CD11a, CD18act and CD18tot expressed on Teff and Treg#1 cells. Ratio CD18act MFI: CD18tot was established to analyze LFA-1 high affinity conformation in indicated conditions. Data are representative of more than three different experiments. Filled gray, negative control; Red line, Teff and Treg cells alone; Green line, cells with APC; Blue line, cells with APC and anti-CD28; and Black line: cells with APC, anti-CD28 and anti-CTLA-4.](http://images.novusbio.com/fullsize/Integrin-beta-2-CD18-Antibody-YFC118-3-Flow-Cytometry-NB200-610-img0015.jpg)
![Immunocytochemistry/Immunofluorescence: Integrin beta 1/CD29 Antibody (12G10) [NB100-63255] - Quantification of knockdown of Beta1 integrin in hS/PC microstructures. hS/PC microstructures formed in HA-based hydrogels and were transfected with scrambled siRNA or ITGB1 siRNA. Immunocytochemistry was used to determine Beta1 integrin expression and spatial distribution of Beta1 integrin 46 h post-transfection. Image analysis software was used to quantify Beta1 integrin expression at microstructure surfaces from confocal micrographs and coverage indices were calculated for scrambled siRNA (A) and ITGB1 siRNA (B) groups where a 63% reduction in Beta1 integrin expression at microstructure surfaces was quantified. Image collected and cropped by CiteAb from the following publication (//www.frontiersin.org/article/10.3389/fcell.2019.00224/full) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/Integrin-beta-1-CD29-Antibody-12G10-Immunocytochemistry-Immunofluorescence-NB100-63255-img0005.jpg "<b>Genetic Strategies Validation. </b>Immunocytochemistry/Immunofluorescence: Integrin beta 1/CD29 Antibody (12G10) [NB100-63255] - Quantification of knockdown of Beta1 integrin in hS/PC microstructures. hS/PC microstructures formed in HA-based hydrogels and were transfected with scrambled siRNA or ITGB1 siRNA. Immunocytochemistry was used to determine Beta1 integrin expression and spatial distribution of Beta1 integrin 46 h post-transfection. Image analysis software was used to quantify Beta1 integrin expression at microstructure surfaces from confocal micrographs and coverage indices were calculated for scrambled siRNA (A) and ITGB1 siRNA (B) groups where a 63% reduction in Beta1 integrin expression at microstructure surfaces was quantified. Image collected and cropped by CiteAb from the following publication (//www.frontiersin.org/article/10.3389/fcell.2019.00224/full) licensed under a CC-BY license.")
![<b>Genetic Strategies Validation. </b>Flow Cytometry: Integrin beta 1/CD29 Antibody (12G10) [NB100-63255] - Flow Cytometry: Integrin beta 1/CD29 Antibody (12G10) [Alexa Fluor 488] [NB100-63255AF488] - A cell surface stain was performed on A549 cells with Integrin beta 1/CD29 (12G10) antibody NB100-63255AF488 (blue) and a matched isotype control NBP1-97005AF488 (orange). Cells were incubated in an antibody dilution of 5 ug/mL for 20 minutes at room temperature. Both antibodies were conjugated to Alexa Fluor 488. Image using the Alexa Fluor 488 form of this antibody.](http://images.novusbio.com/fullsize/Integrin-beta-1-CD29-Antibody-12G10-Flow-Cytometry-NB100-63255-img0003.jpg)
![Immunocytochemistry/Immunofluorescence: Integrin beta 1/CD29 Antibody (12G10) [NB100-63255] - Human salivary gland progenitor cells express integrin beta 1 by day 1 in three-dimensional hyaluronan-based hydrogels. Image from verified customer review.](http://images.novusbio.com/fullsize/Integrin-beta-1-CD29-Antibody-12G10-Immunocytochemistry-Immunofluorescence-NB100-63255-img0004.jpg)
![Flow Cytometry: Integrin beta 1/CD29 Antibody (12G10) [NB100-63255] - Staining of human peripheral blood monocytes with MOUSE ANTI HUMAN CD29.](http://images.novusbio.com/fullsize/Integrin-beta-1-CD29-Antibody-12G10-Flow-Cytometry-NB100-63255-img0002.jpg)
![Western Blot: CIITA Antibody [NBP2-59072] - Analysis of CIITA in rat brain tissue lysate with CIITA antibody at 1 ug/mL.](http://images.novusbio.com/fullsize/CIITA-Antibody-Western-Blot-NBP2-59072-img0006.jpg "Western Blot: CIITA Antibody [NBP2-59072] - Analysis of CIITA in rat brain tissue lysate with CIITA antibody at 1 ug/mL.")
![Immunocytochemistry/Immunofluorescence: CIITA Antibody [NBP2-59072] - Human brain tissue with CIITA antibody.](http://images.novusbio.com/fullsize/CIITA-Antibody-Immunocytochemistry-Immunofluorescence-NBP2-59072-img0008.jpg)
![Immunohistochemistry-Paraffin: CIITA Antibody [NBP2-59072] - Human brain tissue. Antibody concentration of 10 ug/ml.](http://images.novusbio.com/fullsize/CIITA-Antibody-Immunohistochemistry-Paraffin-NBP2-59072-img0004.jpg)
![Flow Cytometry: CD14 Antibody (11-248.2) [NB100-62994] - Staining of human peripheral blood monocytes with Mouse anti Human CD14.](http://images.novusbio.com/fullsize/CD14-Antibody-11-248-2-Flow-Cytometry-NB100-62994-img0016.jpg "Flow Cytometry: CD14 Antibody (11-248.2) [NB100-62994] - Staining of human peripheral blood monocytes with Mouse anti Human CD14.")
![Flow Cytometry: CD14 Antibody (11-248.2) [NB100-62994] Staining of human peripheral blood monocytes with Mouse anti Human CD14](http://images.novusbio.com/fullsize/CD14-Antibody-11-248-2-Flow-Cytometry-NB100-62994-img0009.jpg)
![Flow Cytometry: CD14 Antibody (11-248.2) [NB100-62994] - Staining of human peripheral blood granulocytes with Mouse anti Human CD14.](http://images.novusbio.com/fullsize/CD14-Antibody-11-248-2-Flow-Cytometry-NB100-62994-img0010.jpg)
![Flow Cytometry: CD14 Antibody (11-248.2) [NB100-62994] - Staining of human peripheral blood monocytes probed with Mouse anti Human CD14.](http://images.novusbio.com/fullsize/CD14-Antibody-11-248-2-Flow-Cytometry-NB100-62994-img0011.jpg)
![Flow Cytometry: CD14 Antibody (11-248.2) [NB100-62994] - Staining of human peripheral blood monocytes with Mouse anti Human CD14.](http://images.novusbio.com/fullsize/CD14-Antibody-11-248-2-Flow-Cytometry-NB100-62994-img0012.jpg)
![Flow Cytometry: CD14 Antibody (11-248.2) [NB100-62994] - Staining of human peripheral blood monocytes with Mouse anti Human CD14.](http://images.novusbio.com/fullsize/CD14-Antibody-11-248-2-Flow-Cytometry-NB100-62994-img0013.jpg)
![Flow Cytometry: CD14 Antibody (11-248.2) [NB100-62994] - Staining of human peripheral blood monocytes with Mouse anti Human CD14.](http://images.novusbio.com/fullsize/CD14-Antibody-11-248-2-Flow-Cytometry-NB100-62994-img0014.jpg)
![Flow Cytometry: CD14 Antibody (11-248.2) [NB100-62994] - Staining of human peripheral blood monocytes with Mouse anti Human CD14.](http://images.novusbio.com/fullsize/CD14-Antibody-11-248-2-Flow-Cytometry-NB100-62994-img0015.jpg)
![Western Blot: CD19 Antibody (LE-CD19) [NB100-65672] - analysis of Raji human Lymphoblastic Burkitt's lymphoma whole cell lysate](http://images.novusbio.com/fullsize/CD19-Antibody-LE-CD19-Western-Blot-NB100-65672-img0002.jpg "Western Blot: CD19 Antibody (LE-CD19) [NB100-65672] - analysis of Raji human Lymphoblastic Burkitt's lymphoma whole cell lysate")
![Immunohistochemistry: CD19 Antibody (LE-CD19) [NB100-65672] - Mouse anti human CD19 staining formalin-fixed, paraffin-embedded human tonsil.](http://images.novusbio.com/fullsize/CD19-Antibody-LE-CD19-Immunohistochemistry-NB100-65672-img0001.jpg)
![Western Blot: DARC Antibody - BSA Free [NBP1-77278] - DARC Antibody [NBP1-77278] - DARC expression in monocytes is dependent on an IL-22/IL-22Ra1-STAT5b signaling axis. THP1 cells were incubated with 20 ng/mL IL-22 in the absence or presence of the indicated concentrations of the STAT5b inhibitor, CAS285989, for 24 h and DARC protein expression was determined by immunoblotting assay. Western blot was quantified and expressed as the ratio of DARC and beta-actin intensity. Data are representative of three independent experiments with similar results. Image collected and cropped by CiteAb from the following publication (www.mdpi.com/2073-4409/8/12/1587) licensed under a CC-BY license.](http://images.novusbio.com/fullsize/DARC-Antibody-Western-Blot-NBP1-77278-img0005.jpg "<b>Biological Strategies Validation. </b>Western Blot: DARC Antibody - BSA Free [NBP1-77278] - DARC Antibody [NBP1-77278] - DARC expression in monocytes is dependent on an IL-22/IL-22Ra1-STAT5b signaling axis. THP1 cells were incubated with 20 ng/mL IL-22 in the absence or presence of the indicated concentrations of the STAT5b inhibitor, CAS285989, for 24 h and DARC protein expression was determined by immunoblotting assay. Western blot was quantified and expressed as the ratio of DARC and beta-actin intensity. Data are representative of three independent experiments with similar results. Image collected and cropped by CiteAb from the following publication (www.mdpi.com/2073-4409/8/12/1587) licensed under a CC-BY license.")
![<b>Biological Strategies Validation. </b>Western Blot: DARC Antibody - BSA Free [NBP1-77278] - DARC Antibody [NBP1-77278] - Analysis in human cerebellum tissue lysate with antibody at 1 ug/mL.](http://images.novusbio.com/fullsize/DARC-Antibody-Western-Blot-NBP1-77278-img0004.jpg)
![Immunohistochemistry: DARC Antibody - BSA Free [NBP1-77278] - Immunohistochemistry of DARC in mouse brain tissue with DARC antibody at 2.5 ug/mL.](http://images.novusbio.com/fullsize/nbp1-77278_rabbit-polyclonal-darc-antibody-2711202419553068.jpg)